The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 201–300 of 1,000
Pataky, M. W., Dasari, S., Michie, K. L., Sevits, K. J., Kumar, A. A., Klaus, K. A., Heppelmann, C. J., Robinson, M. M., Carter, R. E., Lanza, I. R., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.010 · Cited by 67
Effects of Acute and Chronic Protein Intake on Metabolism, Appetite, and Ghrelin During Weight Loss
Leidy, H. J., Mattes, R. D., & Campbell, W. W. (2007) · Obesity · doi:10.1038/oby.2007.143 · Cited by 66
“However, neither study adjusted for the age-related changes in metabolism that occur independently of menopause (39).”
BackgroundLiu, L., Simon, B., Shi, J., Mallhi, A. K., & Eisen, H. J. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i18.449 · Cited by 67
D'Eon, T. M., Rogers, N. H., Stancheva, Z. S., & Greenberg, A. S. (2008) · Obesity · doi:10.1038/oby.2008.50 · Cited by 64
Lin, W.-Y., Yang, W.-S., Lee, L.-T., Chen, C.-Y., Liu, C.-S., Lin, C., & Huang, K.-C. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803240 · Cited by 67
Testosterone a key factor in gender related metabolic syndrome
Bianchi, V. E., & Locatelli, V. (2018) · Obesity Reviews · doi:10.1111/obr.12633 · Cited by 78
“hormone in the regulation of glucose homeostasis acting on the brain stimulating energy metabolism (147), on food”
BackgroundMenopausal stages and non-alcoholic fatty liver disease in middle-aged women
Ryu, S., Suh, B.-S., Chang, Y., Kwon, M., Yun, K. E., Jung, H. S., Kim, C., Kim, B.-K., Kim, Y. J., Choi, Y., et al. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.04.017 · Cited by 69
“A higher amount of free fatty acids produced by visceral adipose tissue contributes to decreases in the degradation of apolipoprotein B in the liver, leading to increased production of very low density lipoprotein particles and triglycerides [29,30].”
BackgroundLonden, G. J. V., Perera, S., Vujevich, K. T., Rastogi, P., Lembersky, B. C., Brufsky, A., Vogel, V. G., & Greenspan, S. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1223-2 · Cited by 71
“A prolonged period of profound estrogen suppression and (relative) hyperandrogenemia could be expected to induce major alterations in body composition and cardiovascular risk, possibly more extensive than those induced by menopause [4].”
He, L., Tang, X., Li, N., Wu, Y., Wang, J. W., Li, J. R., Zhang, Z. X., Dou, H.-D., Liu, J. J., Yu, L., et al. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.02.013 · Cited by 65
Protective Effects of Nigella sativa on Metabolic Syndrome in Menopausal Women
Ibrahim, R. M., Hamdan, N. S., Ismail, M., Saini, S. M., Rashid, S. N. A., Latiff, L. A., & Mahmud, R. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2014.005 · Cited by 65
“Fat substitution in different tissues (fat accumulation in visceral tissues) with menopausal transition due to decrease in estrogen secretion is one of the theories about the high prevalence of MetS in menopause women.(13) In this study, body weight of the respondents in N.”
BackgroundDiabetes in Menopause: Risks and Management
Paschou, S. Α., Anagnostis, P. G., Pavlou, D. I., Vryonidou, A., Goulis, D. G., & Lambrinoudaki, I. V. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180625124405 · Cited by 66
Estradiol regulates leptin sensitivity to control feeding via hypothalamic Cited1
González‐García, I., García-Clavé, E., Cebrian-Serrano, A., Thuc, O. L., Contreras, R. E., Xu, Y., Gruber, T., Schriever, S. C., Legutko, B., Lintelmann, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.02.004 · Cited by 68
Ueda, K., & Karas, R. H. (2012) · Steroids · doi:10.1016/j.steroids.2012.12.006 · Cited by 66
Review of cardiovascular risk factors in women
Evangelista, O., & McLaughlin, M. A. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.004 · Cited by 75
Michelsen, T. M., Pripp, A. H., Tonstad, S., Trope, C. G., & Dørum, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.028 · Cited by 68
Karvinen, S. M., Jergenson, M. J., Hyvärinen, M., Aukee, P., Tammelin, T., Sipilä, S., Kovanen, V., Kujala, U. M., & Laakkonen, E. K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00589 · Cited by 70
“, increased serum total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglyceride levels and decreased high-density lipoprotein cholesterol (HDLC) levels] (2).”
BackgroundTorretta, E., Barbacini, P., Al‐Daghri, N. M., & Gelfi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235901 · Cited by 65
Soni, A. C., Conroy, M. B., Mackey, R. H., & Kuller, L. H. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f2e611 · Cited by 68
An overview of host‐derived molecules that interact with gut microbiota
Zhang, C., Liu, H., Sun, L., Wang, Y., Chen, X., Du, J., Sjöling, Å., Yao, J., & Wu, S. (2023) · iMeta · doi:10.1002/imt2.88 · Cited by 66
“In particular, women are more susceptible to these diseases after menopause [91], which highlights that the regulatory effect of estrogen on these diseases is inseparable from the role of gut microbiota.”
BackgroundPeppa, Μ., Koliaki, C. C., Papaefstathiou, A., Garoflos, E., Katsilambros, N. L., Raptis, S., Hadjidakis, D. I., & Dimitriadis, G. (2013) · Obesity · doi:10.1002/oby.20227 · Cited by 68
“Identifying subtypes of obesity is of particular value in postmenopausal women, since menopause-related hormonal changes confer an increased cardiometabolic risk in all postmenopausal women, either they are obese or nonobese (10).”
BackgroundYu, M., Ryu, D., Kim, S., Choi, K.-B., & Kang, D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp483 · Cited by 68
Breast cancer risk in the WHI study: The problem of obesity
Kühl, H. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.02.018 · Cited by 77
“Obese postmenopausal women are at a high risk to develop a metabolic syndrome that is characterized by hypertension, coronary heart disease, dyslipidemia, insulin resistance and hyperinsulinemia [ 61 ].”
BackgroundType 2 Diabetes Mellitus and Menopausal Hormone Therapy: An Update
Paschou, S. Α., & Παπάνας, Ν. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00695-y · Cited by 67
Gorres, B. K., Bomhoff, G. L., Gupte, A. A., & Geiger, P. C. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00541.2010 · Cited by 67
“Clinical evidence suggests postmenopausal women have an increased risk of glucose intolerance and weight gain and that this is accompanied by increased inflammation and decreased insulin sensitivity (7, 33, 42).”
BackgroundWohlers, L. M., & Spangenburg, E. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22553 · Cited by 61
The Role of Sex and Sex Hormones in Regulating Obesity-Induced Inflammation
Varghese, M., Griffin, C. A., & Singer, K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_5 · Cited by 70
Estradiol Drives the Anorexigenic Activity of Proopiomelanocortin Neurons in Female Mice
Stincic, T. L., Grachev, P., Bosch, M. A., Rønnekleiv, O. K., & Kelly, M. J. (2018) · eNeuro · doi:10.1523/eneuro.0103-18.2018 · Cited by 67
“, menopause) women tend to decrease activity and gain body fat with the increase in adiposity correlated to the decline in endogenous estrogens (Carr, 2003; Augoulea et al., 2005; Jasienska et al., 2005).”
BackgroundKaume, L., Gilbert, W. C., Brownmiller, C., Howard, L. R., & Devareddy, L. (2012) · Journal of Functional Foods · doi:10.1016/j.jff.2012.02.008 · Cited by 66
Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study
Heidari, R., Sadeghi, M., Talaei, M., Rabiei, K., Mohammadifard, N., & Sarrafzadegan, N. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-59 · Cited by 67
“Concerning the prevalence of CVD in women (about 22”
BackgroundResultInfluentialLipocalin 2 Deficiency Alters Estradiol Production and Estrogen Receptor Signaling in Female Mice
Guo, H., Zhang, Y., Brockman, D. A., Hahn, W. S., Bernlohr, D., & Chen, X. (2012) · Endocrinology · doi:10.1210/en.2011-1642 · Cited by 66
Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women
Choi, Y., Chang, Y., Kim, B.-K., Kang, D., Kwon, M., Kim, C., Jeong, C., Ahn, Y., Park, H., Ryu, S., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.12.016 · Cited by 61
Gower, B. A., Bergman, R., Stefanovski, D., Darnell, B., Ovalle, F., Fisher, G., Sweatt, S. K., Resuehr, H. S., & Pelkman, C. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0062-5 · Cited by 60
“After menopause, women experience increases in risk for several metabolic diseases including type 2 diabetes and cardiovascular disease [20, 21].”
Gender difference on the development of metabolic syndrome: a population-based study in Taiwan
Hwang, L., Bai, C., Chen, C., & Chien, K. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9183-5 · Cited by 66
“Among young and middle-aged adults, women have lower blood pressure and serum levels of triglyceride, and less abdominal fat accumulation than men [ 14 ].”
BackgroundSex Differences in Cognition Across Aging
Lee, B. H., Richard, J. E., de leon, R. G., Yagi, S., & Galea, L. A. M. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_309 · Cited by 66
Hu, Y., Wang, W.-R., Ma, W., Wang, W., Ren, W., Wang, S., Fu, F., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5475 · Cited by 68
The 2009 Stock Conference Report: Inflammation, Obesity and Metabolic Disease
Hevener, A. L., Febbraio, M. A., & the Stock Conference Working Group (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00691.x · Cited by 63
Wilson, S. G., Adam, G., Langdown, M., Reneland, R., Braun, A. D., Andrew, T., Surdulescu, G. L., Norberg, M., Dudbridge, F., Reed, P., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201551 · Cited by 62
Wang, X., Lu, Y., Wang, E., Zhang, Z., Xiong, X., Zhang, H., Lu, J., Zheng, S., Yang, J., Xia, X., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.029 · Cited by 60
“is associated with an increase in obesity incidence in women [23], while”
BackgroundAhangarpour, A., Najimi, S. A., & Farbood, Y. (2016) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2016.05.006 · Cited by 63
“Estrogen deficiency is associated with the increased probability of weight gain in postmenopausal women.(33) In the current study, body weight was increased, whereas the ovary and uterus weight/body weight percentage was decreased in the D-galactose and Aging group mice.”
BackgroundSerotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
Zha, W., Ho, H. T. B., Hu, T., Hébert, M. F., & Wang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01291-5 · Cited by 65
The brain-adipocyte-gut network: Linking obesity and depression subtypes
Patist, C., Stapelberg, N. J. C., Toit, E. F. D., & Headrick, J. P. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-0626-0 · Cited by 62
“cardiovascular events in menopausal women (Carr, 2003).”
BackgroundBourgonje, A. R., Abdulle, A. E., Al-Rawas, A. M., Al‐Maqbali, M., Al-Saleh, M., Enriquez, M. B., Al‐Siyabi, S., Al-Hashmi, K., Al‐Lawati, I., Bulthuis, M. L. C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21010314 · Cited by 63
“These findings are in line with the current postulation that the female menopause can predispose women to an increased risk of developing cardiovascular disease [19,33].”
Keller, C., Larkey, L., Distefano, J. K., Boehm-Smith, E., Records, K., Robillard, A., Veres, S., Al-Zadjali, M., & O'Brian, A.-M. (2010) · Journal of Women's Health · doi:10.1089/jwh.2009.1547 · Cited by 53
“22 The hormone changes of menopause appear to be intimately linked to many metabolic processes in the body.”
Muñoz, M. J. F., Acevedo, L. B., Pérez, N. C., Martinez, A. L., Gutiérrez, N. T., Vega-García, S., Cruz, A. R., Martínez, A. D., García, R. S., Treviño, A. Z., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.011 · Cited by 60
“Cardiovascular risk and the metabolic syndrome (MS) increase after menopause.(1) Changes in sexual hormone concentrations that occur during this period affect insulin resistance and the distribution of visceral and subcutaneous adipose tissue.”
BackgroundOlivieri, F., Ahtiainen, M., Lazzarini, R., Pöllänen, E., Capri, M., Lorenzi, M., Fulgenzi, G., Albertini, M. C., Salvioli, S., Alen, M. J., et al. (2014) · Aging Cell · doi:10.1111/acel.12245 · Cited by 58
“, 2004) and to increased risk for metabolic disorders and cardiovascular diseases (Carr, 2003).”
BackgroundPark, S., Kim, D. S., Kang, E. S., Kim, D. B., & Kang, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2018 · Cited by 54
“It eventually leads to type 2 diabetes, osteoporosis, cardiovascular diseases, and nonalcoholic steatohepatitis (5, 27).”
BackgroundRegulation of Physiological and Metabolic Function of Muscle by Female Sex Steroids
SPANGENBURG, E. E., GEIGER, P. C., LEINWAND, L. A., & LOWE, D. A. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31825871fa · Cited by 58
“In contrast, following menopause a significant decline in insulin sensitivity occurs along with a corresponding increase in fat mass (11,38).”
BackgroundEstradiol stimulates adipogenesis and Slc2a4/GLUT4 expression via ESR1-mediated activation of CEBPA
de Fátima, L. A., Campello, R. S., Barreto-Andrade, J. N., Passarelli, M., Santos, R. D. S., Clegg, D. J., & Machado, U. F. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.05.006 · Cited by 59
Churilla, J. R., Fitzhugh, E. C., & Thompson, D. L. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0010 · Cited by 58
“28 Females (premenopausal) typically develop peripheral adiposity (gynoid obesity), whereas males more often develop central adiposity (android obesity).”
Magkos, F., Patterson, B. W., & Mittendorfer, B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00246.2006 · Cited by 57
“Premenopausal women have lower plasma TG concentration than men (55); this difference between the sexes is abolished after menopause because of an increase in plasma TG concentration that coincides with the onset of menopause (10).”
Influence of a walking program on the metabolic risk profile of obese postmenopausal women
Roussel, M., Garnier, S., Lemoine, S., Gaubert, I., Charbonnier, L., Auneau, G., & Mauriège, P. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31818d4137 · Cited by 56
“display a hyperandrogenic state, which has often been reported to contribute to the emergence of this condition, thus leading to higher CHD risk.(4)”
BackgroundBlueberries improve glucose tolerance without altering body composition in obese postmenopausal mice
Elks, C. M., Terrebonne, J., Ingram, D. K., & Stephens, J. M. (2015) · Obesity · doi:10.1002/oby.20926 · Cited by 56
“The estrogen decline observed during menopause was once thought to increase MetS risk; however, it is now known that a progressive increase in the “androgenicity” of the hormonal milieu is the primary culprit, not estrogen loss per se (2,3).”
Palmisano, B. T., Stafford, J. M., & Pendergast, J. S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00044 · Cited by 62
“Pre-menopausal women are protected from the negative consequences of obesity such as the metabolic syndrome (22).”
Association between periodontitis and blood lipid levels in a Korean population
Lee, S., Im, A.-J., Burm, E., & Ha, M. (2017) · Journal of Periodontology · doi:10.1902/jop.2017.170111 · Cited by 55
“The prevalence of metabolic syndrome, a composite of high lipid levels, obesity, and high blood pressure, increases with menopause.(16) These are also factors associated with increased risk of cardiovascular disease.”
BackgroundMisra, K. B., Endemann, S. W., & Ayer, M. (2005) · PubMed · Cited by 69
G Protein-Coupled Estrogen Receptor in Energy Homeostasis and Obesity Pathogenesis
Shi, H., Kumar, S. P. D. S., & Liu, X. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00006-6 · Cited by 64
The roles of leptin receptors on POMC neurons in the regulation of sex-specific energy homeostasis
Shi, H., Sorrell, J. E., Clegg, D. J., Woods, S. C., & Seeley, R. J. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.02.018 · Cited by 55
“In humans, pre-menopausal women are more insulin sensitive than age-matched men [10], and the reduction in estrogens during menopause is associated with increased visceral adiposity and the development of glucose intolerance and insulin resistance [11].”
ROSANO, G. M. C., VITALE, C., & FINI, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.031 · Cited by 55
Özdemir, S., Çelik, Ç., Görkemli, H., Kıyıcı, A., & Kaya, B. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.03.016 · Cited by 54
“An increase in serum levels of total cholesterol, LDL cholesterol, and triglycerides [14,18], and a decrease in HDL cholesterol level, have been reported in women in natural menopause [19,20].”
BackgroundVisceral fat and attribute-based medicine in chronic kidney disease
Kataoka, H., Nitta, K., & Hoshino, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1097596 · Cited by 56
Asthma and the menopause: A systematic review and meta-analysis
Zemp, E., Schikowski, T., Dratva, J., Schindler, C., & Probst-Hensch, N. M. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.08.010 · Cited by 54
Menopause: clustering of metabolic syndrome components and population changes in insulin resistance
Lejsková, M., Alusik, S., Suchánek, M., ŽŽecová, S., & Piťťha, J. (2010) · Climacteric · doi:10.3109/13697131003692745 · Cited by 58
Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs
Renner, S., Blutke, A., Dobenecker, B., Dhom, G., Müller, T. D., Finan, B., Clemmensen, C., Bernau, M., Novak, I., Rathkolb, B., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.015 · Cited by 56
Edwards, B. J.-A., & Li, J. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2011.00407.x · Cited by 75
ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue
Kim, M., Neinast, M. D., Frank, A. P., Sun, K., Park, J., Zehr, J. A., Vishvanath, L., Morselli, E., Amelotte, M., Palmer, B. F., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.007 · Cited by 52
“Since fibrosis and inflammation have been causally linked to insulin insensitivity, MetS and T2DM, our studies indicate that loss of Phd3 functionality in AT could have negative metabolic consequences.”
BackgroundInfluentialMenopausa e síndrome metabólica
Meirelles, R. M. R. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002909 · Cited by 81
Covariation of change in bioavailable testosterone and adiposity in midlife women
Janssen, I., Powell, L. H., Jasielec, M. S., & Kazlauskaite, R. (2015) · Obesity · doi:10.1002/oby.20974 · Cited by 51
“VAT increases with menopause, independently of age and total body fat (TBF) as has been shown in cross-sectional (15-18) and longitudinal studies (14,19-22).”
BackgroundMetabolic actions of kisspeptin signaling: Effects on body weight, energy expenditure, and feeding
Hudson, A. D., & Kauffman, A. S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107974 · Cited by 55
RETRACTED: Treatment with Panax Ginseng Antagonizes the Estrogen Decline in Ovariectomized Mice
Xu, Y., Ding, J., Ma, X.-P., Ma, Y.-H., Liu, Z., & Lin, N. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057827 · Cited by 55
“In postmenopausal women, estrogen deficiency is associated with the increased probability of obesity [12].”
BackgroundRetractedDasgupta, S., Salman, M., Lokesh, S., Xaviour, D., Saheb, S. Y., Prasad, B. R., & Sarkar, B. (2012) · Journal of Mid-life Health · doi:10.4103/0976-7800.98814 · Cited by 59
“98814 adiposity, glycemic abnormality, cardiovascular disease (CVD), dyslipidemia, and hypertension.[1-4] The prognosis”
BackgroundBarrera, J., Chambliss, K. L., Ahmed, M., Tanigaki, K., Thompson, B., McDonald, J. G., Mineo, C., & Shaul, P. W. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00653.2013 · Cited by 49
Khristi, V., Ratri, A., Ghosh, S., Pathak, D., Borosha, S., Dai, E., Roy, R., Chakravarthi, V. P., Wolfe, M. W., & Rumi, M. A. K. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.04.005 · Cited by 53
Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome
Ou, Y.-J., Lee, J., Huang, S., Chen, S., Geng, J., & Su, C.-H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134435 · Cited by 54
“The exact mechanism by which menopause increases the risk of metabolic syndrome is not fully understood, but it is believed to be related to hormonal changes that occur during menopause [62,67,68].”
BackgroundChronic diseases in captive geriatric female Chimpanzees (Pan troglodytes).
Nunamaker, E. A., Lee, D. R., & Lammey, M. L. (2012) · PubMed · Cited by 56
Stronger relationship between central adiposity and C-reactive protein in older women than men
Valentine, R. J., Vieira, V. J., Woods, J. A., & Evans, E. M. (2009) · Menopause · doi:10.1097/gme.0b013e31817fcb8f · Cited by 49
“Reductions in estrogen with menopause initiate changes in body morphology such that adipose tissue is preferentially stored centrally in older women, giving a more androgenous fat pattern(21) and increasing the risk of the metabolic syndrome and cardiovascular disease.(22)”
BackgroundTime since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK
Park, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T. A., Kang, C., & Van Pelt, R. E. (2017) · Menopause · doi:10.1097/gme.0000000000000829 · Cited by 44
“Our studies suggest estrogen-mediW production of ovarian hormones, predisposing them to metabolic dysregulation and development of type 2 diabetes.(1) Estrogen-based hormone therapy (HT) not only relieves vasomotor symptoms (eg, hot flashes, sleep disturbances),(2) but reduces incidence of diabetes in”
BackgroundThe effects of progesterones on blood lipids in hormone replacement therapy
Jiang, Y.-F., & Tian, W. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0612-5 · Cited by 53
“Menopause heralds the onset of low levels of high-density lipoprotein cholesterol (HDL-C), high levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), triglycerides (TG) and lipoprotein(a) (Lp(a)), which are strongly predictive of an increasing…”
BackgroundPrasad, M., Sara, J. D. S., Widmer, R. J., Lennon, R. J., Lerman, L. O., & Lerman, A. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.009442 · Cited by 53
“Postmenopausal women may have higher triglyceride levels when compared with premenopausal women, and this may be associated with increased postmenopausal cardiovascular risk.(3,4) This is supported by data that have shown a greater increase in triglyceride levels with age in women versus men.”
ResultMahmoud, A. A., Elfiky, A. M., & Abo-Zeid, F. S. (2021) · Steroids · doi:10.1016/j.steroids.2021.108936 · Cited by 52
Is the adrenal cortex a target for gonadotropins?
Bernichtein, S., Alevizaki, M. K., & Huhtaniemi, I. T. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.06.003 · Cited by 55
López, E. P., Rice, C., Weddle, D. O., & Rahill, G. J. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.10.043 · Cited by 57
“For postmenopausal women, whether the discontinuation in menses is natural or induced, the risk for CVD is greater due to increased low-density lipoprotein (LDL) cholesterol levels, hormonal changes, and age (5).”
BackgroundMenopause modulates the circulating metabolome: evidence from a prospective cohort study
Karppinen, J. E., Törmäkangas, T., Kujala, U. M., Sipilä, S., Laukkanen, J. A., Aukee, P., Kovanen, V., & Laakkonen, E. K. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac060 · Cited by 54
Onions, V. J., WEBB, R., McNeilly, A. S., & Campbell, B. K. (2009) · Human Reproduction · doi:10.1093/humrep/dep274 · Cited by 49
Nestor, C. C., Kelly, M. J., & Rønnekleiv, O. K. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0050 · Cited by 44
“The anorexigenic actions of E2 are critical throughout the lifespan of women, but are particularly important at the time of menopause when women often develop central adiposity, insulin resistance and cardiovascular disease [44].”
BackgroundLaMonte, M. J., Williams, A. M., Genco, R. J., Andrews, C., Hovey, K. M., Millen, A. E., Browne, R. W., Trevisan, M., & Wactawski‐Wende, J. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.140185 · Cited by 49
Mishra, A., Wang, Y., Yin, F., Vitali, F., Rodgers, K. E., Soto, M., Mosconi, L., Wang, T., & Brinton, R. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101542 · Cited by 60
“The prevalence and severity of metabolic syndrome increase with endocrinological aging, potentially due to estrogen deficiency, increased circulating androgen, and peripheral metabolic reprograming (Carr, 2003; Gurka et al., 2016; Janssen et al., 2008; Rettberg et al., 2014; Stefanska et al., 2015).”
BackgroundPark, J. S., Nam, J. S., Cho, M. H., Yoo, J. S., Ahn, C. W., Jee, S. H., Lee, H. S., Soo, B., Kim, K. R., & Lee, H. C. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181cd3d60 · Cited by 56
“After menopause, there is a loss of ovarian function, and a three- to eightfold increase in the risk of CVD.(1) Although it is not clear how the estrogen deficiency leads to increased cardiovascular risks, several reports have suggested that the estrogen deficiency affects the body fat distribution, and the resultant…”
BackgroundInfluentialPanov, A. V., Mayorov, V., & Dikalov, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074047 · Cited by 50
“It is crucial that the emergence of MetS in the postmenopause period does not depend on the body mass index and physical activity [34] but may depend, in women, on the dynamics of estrogen decline with age [35].”
BackgroundNakajima, Y., Yamada, M., Akuzawa, M., Ishii, S., Masamura, Y., Satoh, T., Hashimoto, K., Negishi, M., Shimomura, Y., Kobayashi, I., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1353 · Cited by 53
Tang, R., Fan, Y., Luo, M., Zhang, D., Xie, Z., Huang, F., Wang, Y., Liu, G., Wang, Y., Lin, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814872 · Cited by 47
Zhang, H., Chen, X., & Sairam, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-2008 · Cited by 46
“Menopausal transition (low estrogen/androgen ratio) increases the rates of obesity and metabolic syndrome during aging in women (46).”
BackgroundComorbidities in women living with HIV: A systematic review
Raffe, S. F., Sabin, C. A., & Gilleece, Y. C. (2022) · HIV Medicine · doi:10.1111/hiv.13240 · Cited by 51
Leung, K., Xu, A., Craig, M. E., Martin, A. M., Lam, K. S. L., & O’Sullivan, A. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.020 · Cited by 49
“The fall of female sex steroids in postmenopausal women is associated with an increase in abdominal adiposity and insulin resistance [2], and these changes are reduced”
BackgroundLi, S., Tan, I., Atkins, E., Schutte, A. E., & Gnanenthiran, S. R. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00672-y · Cited by 54
“It was found that urinary calcium excretion decreased in a dose-dependent cardiovascular risk [69 ].”
BackgroundNatural Postmenopause Is Associated With an Increase in Combined Cardiovascular Risk Factors
LEJSKOVÁ, M., ALUŠÍK, Š., VALENTA, Z., ADÁMKOVÁ, S., & PIŤHA, J. (2012) · Physiological Research · doi:10.33549/physiolres.932313 · Cited by 46
“…2010), which may affect only the part of the population at higher risk (Lejsková et al. 2011) and metabolic effects of menopause may not be unique (Carr 2003, Feng et al. 2008), with single MS components not necessarily being identical in the period of their postmenopausal rise (Cho et al. 2008).”
BackgroundSpencer, K. L., Malinowski, J. R., Carty, C. L., Franceschini, N., Fernández‐Rhodes, L., Young, A., Cheng, I. C., Ritchie, M. D., Haiman, C. A., Wilkens, L. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055258 · Cited by 49
“These ANM associations and suggestive AM associations with genes involved in cardiovascular function, lipid metabolism, and type 2 diabetes concur with research showing later AM lowers obesity and diabetes risk while earlier ANM increases risk for cardiovascular disease, obesity and insulin resistance [90,91].”
ResultThe Triglyceride Paradox in Stroke Survivors: A Prospective Study
Jain, M., Jain, A. R., Yerragondu, N., Brown, R. D., Rabinstein, A. A., Jahromi, B. S., Vaidyanathan, L., Blyth, B. J., & Ganti, L. (2013) · Neuroscience Journal · doi:10.1155/2013/870608 · Cited by 46
“It has been reported in the past that on transition from pre- to postmenopausal women often develop features of metabolic syndrome [21] and nearly a 16% increase in triglyceride levels [22].”
BackgroundVariation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
High-Fat Feeding Improves Anxiety-Type Behavior Induced by Ovariectomy in Rats
Dornellas, A. P. S., Boldarine, V. T., Pedroso, A. P., Carvalho, L. O. T., de Andrade, I. S., Vulcani-Freitas, T. M., dos Santos, C. C. C., do Nascimento, C. M. D. P. O., Oyama, L. M., & Ribeiro, E. B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00557 · Cited by 46
“Estrogen deficiency has been associated with increased body adiposity, impairment of plasma lipid profile, type 2 diabetes and metabolic syndrome (Milewicz et al., 1996; Carr, 2003; Messina et al., 2013).”
BackgroundTargeting Abdominal Obesity and Its Complications with Dietary Phytoestrogens
Kuryłowicz, A., Cakala, M., & Puzianowska‐Kuźnicka, M. (2020) · Nutrients · doi:10.3390/nu12020582 · Cited by 49
“In clinical studies, menopause has been found to be associated with a constant decline in insulin sensitivity that is parallel to the increase in serum inflammatory markers and an unfavorable lipid profile [81].”
Background
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.